- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Waverley Pharma Inc (WAVE)Waverley Pharma Inc stock price live, this page displays TSXV WAVE stock exchange data. View the WAVE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Waverley Pharma Inc real time stock price chart below.
What Is the Waverley Pharma Inc Stock Price Today?
The Waverley Pharma Inc stock price today is 0.0200.
What Is the Stock Symbol for Waverley Pharma Inc?
The stock symbol for Waverley Pharma Inc is "WAVE."
What Stock Exchange Does Waverley Pharma Inc Trade On?
Waverley Pharma Inc is listed and trades on the TSXV stock exchange.
Is Waverley Pharma Inc a Good Stock to Buy?
Determining whether Waverley Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the WAVE quote. (ISIN: CA94357L1058)
What Is the Waverley Pharma Inc Stock Price Today?
The Waverley Pharma Inc stock price today is 0.0200.
What Is the Stock Symbol for Waverley Pharma Inc?
The stock symbol for Waverley Pharma Inc is "WAVE."
What Stock Exchange Does Waverley Pharma Inc Trade On?
Waverley Pharma Inc is listed and trades on the TSXV stock exchange.
Is Waverley Pharma Inc a Good Stock to Buy?
Determining whether Waverley Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the WAVE quote. (ISIN: CA94357L1058)
TSXV
Currency in CAD
0.0200
0.0000(0.00%)
Delayed Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0200
0.0200
52 wk Range
0.0100
0.0350
WAVE Scorecard
Full Analysis
Stock generally trades with high price volatility
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.02000.0200
52 wk Range
0.01000.0350
Key Statistics
Edit
Fair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockWAVE Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Waverley Pharma Inc Company Profile
Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom. It also focuses on generic oncology injectable products. The company offers generic oncology products, such as temozolomide, capecitabine, and erlotinib. It also provides injectable generic chemotherapy drugs, such as pemetrexed for the treatment of non-small cell lung cancer and other indications; and bortezomib to treat multiple myeloma and other indications. In addition, the company develops PARP-1 inhibitors for cancer treatment. Waverley Pharma Inc. was founded in 2014 and is headquartered in Winnipeg, Canada.
Compare WAVE to Peers and Sector
Metrics to compare | WAVE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipWAVEPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.5x | −4.3x | −0.7x | |
PEG Ratio | 0.00 | −0.02 | 0.00 | |
Price/Book | −0.5x | −0.3x | 2.6x | |
Price / LTM Sales | 15.2x | 3.9x | 3.2x | |
Upside (Analyst Target) | - | 206.8% | 43.2% | |
Fair Value Upside | Unlock | −28.9% | 6.8% | Unlock |
FAQ
What Is the Waverley Pharma (WAVE) Stock Price Today?
The Waverley Pharma stock price today is 0.02
What Stock Exchange Does Waverley Pharma Trade On?
Waverley Pharma is listed and trades on the TSXV stock exchange.
What Is the Stock Symbol for Waverley Pharma?
The stock symbol for Waverley Pharma is "WAVE."
What Is the Waverley Pharma Market Cap?
As of today, Waverley Pharma market cap is 1.08M.
What is Waverley Pharma Earnings Per Share?
The Waverley Pharma EPS is -0.041.
From a Technical Analysis Perspective, Is WAVE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.